Background: To analyse available evidence on the efficacy and safety of anti-TNFα drugs (infliximab, etanercept and adalimumab) for treating rheumatoid arthritis (RA). Methods: We searched ...

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

In the REFLEX trial, patients who had an inadequate response to TNF antagonists and who were on weekly MTX with mean disease duration of 12 years were studied. [18] They were randomized to receive ...

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha. Clin. Rheumatol. 29 , 517–524 (2010).

some medications used to treat rheumatoid arthritis may increase your chances of developing psoriasis. While it isn’t common, some people taking immunosuppressant drugs called tumor necrosis ...

104, No. 2 (2021), pp. 1-10 (10 pages) No consistent results have been reached on the relationship of interleukin-1 (IL-1) rs1800587 polymorphism with the susceptibility to rheumatoid arthritis (RA) ...

ALLAN GIBOFSKY: In rheumatoid arthritis, a person's immune system ... a particular cytokine from causing inflammation. Tumor Necrosis Factor, or TNF, occurs naturally in the body.

Increasing wildfire incidence, along with greater overall air pollution, may be contributing to risks for rheumatoid arthritis and RA ... in Nature Communications. TNF inhibitor use demonstrates ...